Changing the Paradigm of Cancer Drug Discovery and Development with Plants

iBio's Martin Brenner and Randy Maddux; and oncology pipeline advisor Steven King discuss how they are recruiting creative scientific talent, pioneering new approaches, and leveraging iBio’s FastPharming System to deliver additional therapeutic options to the market.

    • Tags:

Nice Insight

Nice Insight, established in 2010, is the research division of That’s Nice, A Science Agency, providing data and analysis from proprietary annual surveys, custom primary qualitative and quantitative research as well as extensive secondary research. Current annual surveys include The Nice Insight Contract Development & Manufacturing (CDMO/CMO), Survey The Nice Insight Contract Research - Preclinical and Clinical (CRO) Survey, The Nice Insight Pharmaceutical Equipment Survey, and The Nice Insight Pharmaceutical Excipients Survey.

Q: